Total Insider Purchases and Sales Reported to the SEC. The Morrisville, North Carolina-based company said it … Historical daily share price chart and data for Tenax Therapeutics since 1997 adjusted for splits. Analyst Ratings. There are currently no items in this Watchlist. The stock price of Tenax Therapeutics (NASDAQ: TENX) – a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need – increased by over 35% during intraday trading. The stock has a consensus analyst rating of "Buy." Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company's main product is levosimendan. Copyright © 2021 MarketWatch, Inc. All rights reserved. TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket InvestorPlace Jan 19, 2021 GME, LAC, AMC and COHR among premarket gainers Seeking Alpha Jan 19, 2021 Company Name: Tenax Therapeutics Inc., Stock Symbol: TENX, Industry: Medical - Drugs, Total Posts: 8113, Last Post: 4/10/2021 11:53:02 PM Comparatively, Exact Sciences has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. The specialty pharmaceutical company reported ($1.64) earnings … The all-time high Tenax Therapeutics stock closing price was 11982.01 on March 02, 2000.; The Tenax Therapeutics 52-week high stock price is 3.68, which is 102.2% above the current share price. The Price And Volume Action In Tenax Therapeutics's Stock Today Tenax Therapeutics (NASDAQ: TENX) is currently up 102.8% to a price of $2.39. Cookie Notice (). Tenax Therapeutics, Inc. (TENX) Quote Overview ... A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. View Tenax Therapeutics, Inc. TENX investment & stock information. Tenax Therapeutics' stock was trading at $1.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. This browser is no longer supported at MarketWatch. This browser is no longer supported at MarketWatch. Log in to see them here or sign up to get started. The boost came after an analyst at Ladenburg Thalmann Financial Services said he was “encouraged” by the specialty pharmaceutical company’s update on its study of patients with difficult-to-treat pulmonary hypertension. A high-level overview of Tenax Therapeutics, Inc. (TENX) stock. Since then, TENX stock has increased by 98.1% and is now trading at $2.06. Do you have to pay taxes on withdrawals from 529 college-savings plans? View the latest Tenax Therapeutics Inc. (TENX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Post-Market 0.05 (2.49%) Dive deeper with interactive charts and top stories of TENAX THERAPEUTICS, INC.. Privacy Notice, and The latest closing stock price for Tenax Therapeutics as of April 16, 2021 is 1.82.. Customizable interactive chart for Tenax Therapeutics with latest real-time price quote, charts, latest news, technical analysis and opinions. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Tenax Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Tenax Therapeutics's TENX shares and potentially its market environment have been in a bullish cycle in … For the best MarketWatch.com experience, please update to a modern browser. With Tenax Therapeutics stock trading at $1.79 per share, the total value of Tenax Therapeutics stock (market capitalization) is $22.59M. TENX: Get the latest Tenax Therapeutics stock price and detailed information including TENX news, historical charts and realtime prices. The company has a world-class scientific advisory team, including recognized global experts in pulmonary hypertension. Tenax Therapeutics Inc (TENX : NASDAQ) Stock Price & News - Google Finance. Tenax Therapeutics Inc. NASDAQ Updated May 13, 2021 8:51 PM TENX 2.01 0.09 (4.29%). The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. Historical and current end-of-day data provided by FACTSET. Tenax Therapeutics Inc stock has gained 210.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives TENX stock a score of 69 out of a possible 100.. That rank is influenced by a fundamental score of 88. Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. Tenax Therapeutics, Inc. is a specialty pharmaceutical company. By using this site you agree to the Tenax Therapeutics, Inc. Common Stock, also called Tenax Therapeutics, is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. For the best MarketWatch.com experience, please update to a modern browser. Tenax Therapeutics stock was originally listed at a price of $1,168.83 in Dec 31, 1997. View which stocks have been most impacted by COVID-19. Cookie Notice (). The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. Tenax Therapeutics has a beta of 2.46, meaning that its stock price is 146% more volatile than the S&P 500. Investors appear to be responding to the company announcing that. Visit a quote page and your recently viewed tickers will be displayed here. TENX | Complete Tenax Therapeutics Inc. stock news by MarketWatch. Subscriber Agreement & Terms of Use, Phone 1 919 855-2100. Tenax Therapeutics Inc. ONE Copley Parkway. Overview. Copyright © 2021 MarketWatch, Inc. All rights reserved. Tenax Therapeutics (NASDAQ:TENX) posted its earnings results on Monday. View the latest ratings for TENX. Privacy Notice, and TENX stock … The company has a world-class scientific advisory team, including recognized global experts in pulmonary hypertension. The Company is focused on identifying, developing and commercializing products for the critical care market. Sector Health Care/Life Sciences. Tenax Therapeutics Description. Have Watchlists? Visit a quote page and your recently viewed tickers will be displayed here. Create a list of the investments you want to track. Subscriber Agreement & Terms of Use, Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find the latest Institutional Holdings data for Tenax Therapeutics, Inc. Common Stock (TENX) at Nasdaq.com. TENX, Tenax Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines When did Tenax Therapeutics' stock split? All quotes are in local exchange time. TENX Stock Rockets on Analyst Coverage While Tenax Therapeutics didn’t issue any news this morning, the company didn’t have to. Intraday Data provided by FACTSET and subject to terms of use. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. Industry Biotechnology. Something went wrong while loading Watchlist. Stock. View real-time stock prices and stock quotes for a full financial overview. View the latest TENX stock quote and chart on MSN Money. Historical and current end-of-day data provided by FACTSET. Here’s how to avoid an unpleasant surprise, Israel, Hamas close to cease-fire amid mounting international pressure, CEO of TikTok parent ByteDance to step down, Thai Airways creditors approve reorganization plan, Ford unveils electric F-150, making big bet that buyers will embrace it, End of an era: Microsoft’s Internet Explorer to be retired next year, ‘Everyone’s feeling this’: People are using alcohol to cope with pandemic-related stress — here’s how to drink less, The IRS backlog of 2019 tax returns keeps shrinking — but now for the bad news. Suite 490. Morrisville, North Carolina 27560. Create a list of the investments you want to track. Log in to see them here or sign up to get started. All quotes are in local exchange time. Have Watchlists? There are currently no items in this Watchlist. MORRISVILLE, N.C. (AP) _ Tenax Therapeutics Inc. (TENX) on Monday reported a loss of $23.7 million in its first quarter. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Intraday data delayed at least 15 minutes or per exchange requirements. Fiscal Year-end … The company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding its Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). Tenax Therapeutics (NASDAQ:TENX) was among the trending tickers on Yahoo Finance today, increasing by over 15% to $2.10 USD by 2:30 pm EST. Tenax Therapeutics Inc () Stock Market info Recommendations: Buy or sell Tenax Therapeutics stock? Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. Intraday Data provided by FACTSET and subject to terms of use. The acquisition also has Tenax Therapeutics issuing 12.1 million unregistered shares of common stock and securities convertible into common stock to PH Precision Med shareholders. Get Tenax Therapeutics Inc (TENX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. ‒‒:‒‒. Something went wrong while loading Watchlist. By using this site you agree to the Here’s how to avoid an unpleasant surprise, Israel, Hamas close to cease-fire amid mounting international pressure, CEO of TikTok parent ByteDance to step down, Thai Airways creditors approve reorganization plan, Ford unveils electric F-150, making big bet that buyers will embrace it, End of an era: Microsoft’s Internet Explorer to be retired next year, ‘Everyone’s feeling this’: People are using alcohol to cope with pandemic-related stress — here’s how to drink less, The IRS backlog of 2019 tax returns keeps shrinking — but now for the bad news, H.C. Wainwright Keeps a Buy Rating on Tenax Therapeutics (TENX), TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket. Tenax Therapeutics currently has 1 buy rating from Wall Street analysts. Tenax Therapeutics, Inc. Common Stock (TENX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. The company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding its Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today... TENX : 2.06 (+2.49%) Tenax Therapeutics, …
I Live In A Flat British Council, Site Pour Regarder Des Animes En Français, Avito Appartement Fès Montfleuri 2, Terrasse Bois Ou Carrelage Imitation Bois, Saumon Poché Bouillon Poulet, Filet De Rouget Au Four Courgette, Réglementation Terrasse Sur Trottoir,